Plasma vascular endothelial growth factor level is elevated in patients with multivessel coronary artery disease

被引:25
|
作者
Nakajima, K
Tabata, S
Yamashita, Y
Kusuhara, M
Arakawa, K
Ohmori, R
Yonemura, A
Higashi, K
Ayaori, M
Nakamura, J
Ohsuzu, F
机构
[1] Natl Def Med Coll, Dept Internal Med 1, Saitama, Japan
[2] Mitsukoshi Hlth & Welfare Fdn, Tokyo, Japan
关键词
vascular endothelial growth factor; ischemia; atherosclerosis; severity; coronary artery disease; cytokine;
D O I
10.1002/clc.4960270509
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Vascular endothelial growth factor (VEGF) has been implicated in both angiogenesis and ischemia. However, the relationship between plasma VEGF level and coronary artery disease remains unknown. Hypothesis: Plasma VEGF level may be associated with severe coronary artery disease and other cardiovascular risk factors. Methods: We examined plasma VEGF concentration and coronary risk factors in 73 patients who underwent coronary angiography and 70 apparently healthy control subjects. According to the number of the three major coronary vessels with significant (greater than or equal to 75%) stenosis, we divided the patients into two groups: the mild stenosis group (0- and single-vessel disease. n = 36) and the severe stenosis group (double- and triple-vessel disease, n = 37). Results: The loa VEGF value of the severe stenosis group was significantly higher than that of the mild sterrosis (p < 0.05) and control groups (p < 0.05). Furthermore, there was a significant positive trend in the log VEGF value according to the number of vessels with significant stenosis (p = 0.016). However. there was no significant difference in log VEGF value between the mild stenosis and control groups. Soluble vascular cellular adhesion molecule, soluble intracellular adhesion molecule, and other coronary risk factors were found to be associated with the presence of vessel stenosis. Conclusion: Unlike established coronary risk factors, the plasma VEGF level may be associated with only severe coronary ischemia such as multiple coronary vessel disease.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 50 条
  • [1] The relationship between severity of coronary artery disease and plasma level of vascular endothelial growth factor
    Kucukardali, Yasar
    Aydogdu, Sebnem
    Ozmen, Namik
    Yonem, Arif
    Solmazgul, Emrullah
    Ozyurt, Mustafa
    Cingozbay, Yilmaz
    Aydogdu, Aydogan
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2008, 9 (02) : 66 - 70
  • [2] Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease
    Alber, HF
    Frick, M
    Dulak, J
    Dörler, J
    Zwick, RH
    Dichtl, W
    Pachinger, O
    Weidinger, F
    [J]. HEART, 2005, 91 (03) : 365 - 366
  • [3] Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease
    Alber, HF
    Dulak, J
    Frick, M
    Dichtl, W
    Schwarzacher, SP
    Pachinger, O
    Weidinger, F
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) : 1951 - 1955
  • [4] Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease
    T. Soeki
    Yoshiyuki Tamura
    Hisanori Shinohara
    Hideji Tanaka
    Kanji Bando
    Nobuo Fukuda
    [J]. Heart and Vessels, 2000, 15 : 105 - 111
  • [5] Role of circulating vascular endothelial growth factor and hepatocyte growth factor in patients with coronary artery disease
    Soeki, T
    Tamura, Y
    Shinohara, H
    Tanaka, H
    Bando, K
    Fukuda, N
    [J]. HEART AND VESSELS, 2000, 15 (03) : 105 - 111
  • [6] Vascular profile of patients with multivessel coronary artery disease
    Rigatelli, G
    Rigatelli, G
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 106 (01) : 35 - 40
  • [7] IMPACT OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) ON CORONARY ARTERY DISEASE IN DIALYSIS PATIENTS
    Bantis, Christos
    Aker, Sendogan
    Schwandt, Christina
    Kuhr, Nicola
    Kouri, Nicoletta-Maria
    Heering, Peter
    Rump, Lars-Christian
    Ivens, Katrin
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [8] Elevated plasma homocysteine level as a risk factor for coronary artery disease
    Dzielinska, Z
    Kadzìela, J
    Dabrowski, M
    Sitkiewicz, D
    Kruk, M
    Przyluski, J
    Deptuch, T
    Ruzyllo, W
    [J]. EUROPEAN HEART JOURNAL, 2000, 21 : 455 - 455
  • [9] Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease
    Henry, TD
    Rocha-Singh, K
    Isner, JM
    Kereiakes, DJ
    Giordano, FJ
    Simons, M
    Losordo, DW
    Hendel, RC
    Bonow, RO
    Eppler, SM
    Zioncheck, TF
    Holmgren, EB
    McCluskey, ER
    [J]. AMERICAN HEART JOURNAL, 2001, 142 (05) : 872 - 880
  • [10] Vascular Endothelial Growth Factor Gene Polymorphisms in Susceptibility to Coronary Artery Disease
    Awata, Takuya
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2010, 23 (09) : 938 - 939